Home » Biotechnology » DNA Probe-Based Diagnostics Market

DNA Probe-Based Diagnostics Market By Applications (Infectious Diseases, Cancer, Genetic Predisposition, Identity/forensics, Others)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Actionable Insights Delivered –DNA Probe-Based Diagnostics Market Size

Positioned with a USD 14.2 billion valuation in 2022, the DNA Probe-Based Diagnostics Market asserted its global eminence. Set to scale to USD 20.11 billion by 2030, the market’s remarkable Compound Annual Growth Rate (CAGR) of 5.10% (2022-2030) underscores its strategic growth trajectory.

Key Highlights of the Report

The global DNA probe-based diagnostics market is segmented by application and region. Infectious Diseases are the most popular, while cancer, genetic predisposition, and identity/forensics are the primary user segments, with Asia Pacific leading the market growth.

The global DNA probe-based diagnostics market has several drivers, including DNA probe-based diagnostics offering high specificity and sensitivity for detecting and identifying particular genetic sequences. These probes are made to specifically bind to complementary DNA or RNA targets, making it possible to accurately detect pathogens, genetic mutations, and other disease-related biomarkers. However, the market also faces significant challenges, such as the price of DNA probe-based diagnostics.

Nonetheless, the global DNA probe-based diagnostics market offers significant growth opportunities, including huge growth potential in the Asia Pacific region, advances in high-throughput sequencing technologies, and our growing understanding of the human genome.

What Are The Main Drivers Of The Global DNA Probe-Based Diagnostics Market?

The global DNA probe-based diagnostics market is driven by several factors, including DNA probe-based diagnostics providing quick and effective testing options. These tests can now be carried out quickly, with results frequently available within hours, thanks to improvements in molecular biology techniques.

What Are The Major Challenges Faced By The Global DNA Probe-Based Diagnostics Market?

The global DNA probe-based diagnostics market also faces several challenges, including the high cost per test may restrict the affordability and accessibility of these diagnostics, particularly in healthcare settings with limited resources.

What Are The Growth Opportunities In The Global DNA Probe-Based Diagnostics Market?

The global DNA probe-based diagnostics market offers significant growth opportunities, including infectious disease prevalence continues to be a significant healthcare concern.

Executive Summary

Overview of the Global DNA Probe-Based Diagnostics Market

The global DNA probe-based diagnostics market has been steadily growing in recent years, driven by These diagnostics being widely used in many fields, including pharmacogenomics, genetic testing, cancer diagnostics, and the diagnosis of infectious diseases. The market is characterized by various materials, designs, and sizes, catering to diverse consumer preferences.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Definition

Biological samples like blood, saliva, tissue, or bodily fluids are obtained from patients or subjects of an investigation. DNA or RNA is extracted from the collected samples to obtain the desired genetic material. If the target sequences are present in the sample, the extracted DNA or RNA is combined with particular DNA probes that are made to hybridize (bind) to them. Bound DNA probes can be found using fluorescence, chemiluminescence, or radioactive signals. This makes it possible to determine whether the target DNA or RNA sequences are present. Medical professionals or researchers interpret the findings, and the detection signals are used to estimate the presence and quantity of the target DNA or RNA sequences.

Market Insights

The global demand for DNA probe-based diagnostics was valued at USD 14.2 Billion in 2022 and is expected to reach USD 20.11 Billion in 2030, growing at a CAGR of 5.10% between 2023 and 2030.
Infectious diseases are the leading segment by applications and held over 43% share in value in 2022, while the cancer segment is likely to exhibit the fastest CAGR during the forecast period.
Asia Pacific is fueling the growth of the DNA probe-based diagnostics industry with over one-third share in 2022, while North America and Europe collectively account for just under 50% share in 2022. Europe held over 22% share in 2022.
DNA probe-based diagnostics are essential for personalized medicine because they allow for customized treatments based on a person’s genetic profile as our knowledge of the genetic basis of diseases continues to grow and are the major market drivers. At the same time, the market for DNA probe-based diagnostics is also constrained by regulatory issues. Obtaining regulatory approvals can take time and money, and adhering to strict regulatory frameworks is the main restraint.
The huge growth potential in the Asia Pacific and the demand for accurate and dependable DNA probe-based diagnostics in oncology is anticipated to increase as cancer incidence continues to rise globally are the major opportunities in the market.

Segmentation by Application

Infectious diseases are the leading segment by applications and held over 43% share in value in 2022.
The cancer segment will likely exhibit the fastest CAGR during the forecast period.
Genetic predisposition is another segment but contributes very little to the global DNA probe-based diagnostics market compared to the other segments.

Segmentation by Region

Asia Pacific is fueling the growth of the DNA probe-based diagnostics industry with over one-third share in 2022.
North America and Europe collectively account for just under 50% share in 2022, with Europe holding over 22% share in the same year.
The rest of the World, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for DNA probe-based diagnostics.

The increasing demand for DNA probe-based diagnostics can be attributed to the usability and accessibility of DNA probe-based diagnostic platforms have been enhanced by ongoing technological and automated advancements. Automated systems and integrated software solutions have made the testing process simpler, which also require less manual labor and expertise. Due to this, DNA probe-based diagnostics are now more widely available in various healthcare settings, such as hospitals, clinics, and research labs.

Healthcare professionals have been encouraged to incorporate these tests into their regular practice by the availability of user-friendly diagnostic platforms, which has further fueled market growth. However, the market is restrained by online games and economic uncertainty.

The United States is one of North America’s largest markets for DNA probe-based diagnostics, with a significant market share. Ongoing research and development in the fields of genomics and molecular diagnostics. New probe designs, improved detection methodologies, and amplification techniques are constantly being developed to improve sensitivity, specificity, and multiplexing capabilities. These innovations increase the precision and dependability of DNA probe-based diagnostics and provide new opportunities for identifying uncommon genetic variants and emerging pathogens. leading to a surge in sales in the U.S.

China is also a major market for DNA probe-based diagnostics in the Asia Pacific region, with a significant market share. DNA probe-based diagnostic innovation is still driven by ongoing research and development in genomics and molecular diagnostics. Increased sensitivity, specificity, and multiplexing capabilities are constantly being developed by developing new probe designs, detection methodologies, and amplification techniques. These innovations increase the precision and dependability of DNA probe-based diagnostics and provide new opportunities for identifying uncommon genetic variants and emerging pathogens.

Overall, the market for DNA probe-based diagnostics is propelled by the demand for precise and quick diagnostic tools, the growing application fields of molecular diagnostics, technological advancements, and ongoing research and development activities. The market for DNA probe-based diagnostics is predicted to expand significantly over the next few years as researchers and healthcare professionals continue to see their advantages and potential.

Development And Widespread Use In The Healthcare Sector

Several factors that have fueled its development and widespread use in the healthcare sector drive the market for DNA probe-based diagnostics. Healthcare professionals and researchers worldwide favor this cutting-edge technology because it has many advantages over conventional diagnostic techniques. First, DNA probe-based diagnostics offer excellent sensitivity and specificity for detecting and identifying genetic sequences. To accurately detect pathogens, genetic mutations, and other disease-related biomarkers, these probes are made to bind specifically to complementary DNA or RNA targets. Since there are fewer false-positive and false-negative results as a result of the high level of specificity, healthcare professionals can make wise decisions about patient care.

Quick And Effective Testing Options

The second benefit is the quick and effective testing options provided by DNA probe-based diagnostics. These tests can now be completed quickly and frequently yield results in just a few hours thanks to improvements in molecular biology techniques. In emergencies, where prompt diagnosis is essential for successful treatment and patient management, a quick turnaround time is essential. The effectiveness and affordability of DNA probe-based diagnostics are further improved by the capability to run multiple tests concurrently on a single sample using multiplex probe technology. Additionally, their expanding application fields influence the market growth of DNA probe-based diagnostics. These diagnostics are widely used in various fields, including pharmacogenomics, genetic testing, cancer diagnostics, and the diagnosis of infectious diseases. DNA probe-based diagnostics are essential to personalized medicine because they allow for customized treatments based on a person’s genetic profile as our knowledge of the genetic basis of diseases continues to grow. DNA probe-based diagnostics are increasingly being used, which is furthering market expansion. This is due to the rising demand for precision medicine and targeted therapies.

High Cost Per Test

The price of DNA probe-based diagnostics is one of the main obstacles. Initial costs for the infrastructure, reagents, and equipment needed for specialized laboratories can be high. Additionally, the high cost per test may restrict the affordability and accessibility of these diagnostics, particularly in healthcare settings with limited resources. Some healthcare providers need help to implement DNA probe-based diagnostics on a large scale due to the high cost of the tests and the requirement for skilled personnel to perform and interpret them.

The market for DNA probe-based diagnostics is also constrained by regulatory issues. It can take a lot of time and money to obtain regulatory approvals and adhere to strict regulatory frameworks. The diagnostic platforms and probes must adhere to legal requirements for reliability, efficiency, and quality. The complex and constantly changing nature of molecular diagnostics frequently necessitates constant updates and validation of assays, which can further delay market entry and raise costs for diagnostic manufacturers. Another drawback of DNA probe-based diagnostics is the need for labor-intensive and complicated sample preparation procedures. The DNA or RNA extracted from the patient’s sample must be of high quality and purity for these tests to be successful.

Difficult To Collect, Transport, And Extract Samples

Collecting, transporting, and extracting samples can be difficult, especially in remote or low-resource locations. The widespread adoption of DNA probe-based diagnostics may need to be improved by requiring trained personnel, specialized equipment, and strict quality control procedures in sample preparation. Additionally, the market is constrained by competition from alternative diagnostic technologies. While DNA probe-based diagnostics have high specificity and sensitivity, other diagnostic techniques like polymerase chain reaction (PCR), next-generation sequencing (NGS), and immunoassays produce trustworthy results. These alternative technologies have benefits, such as multiplexing abilities, high-throughput analysis, and affordability. In some situations and applications, it may be difficult for DNA probe-based diagnostics to capture a sizable market share due to the variety of diagnostic options available. Additionally, it may be difficult and necessitate specialized knowledge to interpret diagnostic results obtained using DNA probes. Healthcare professionals with extensive training in molecular diagnostics may find it easier to design and optimize probes, choose appropriate controls, and interpret the hybridization signals. This could affect the tests’ dependability and credibility by causing results to vary and be interpreted incorrectly.

High-Throughput Sequencing Technologies

The demand for DNA probe-based diagnostics has increased as a result of advances in high-throughput sequencing technologies and our growing understanding of the human genome. By identifying disease propensity, enabling personalized medicine, and facilitating targeted therapies, these techniques provide useful information about a person’s genetic makeup. The market for DNA probe-based diagnostics is anticipated to expand significantly with the advancement of genomics research. Infectious disease prevalence continues to be a significant healthcare concern. Early diagnosis and prompt treatment are made possible by DNA probe-based diagnostics, which provide quick and accurate detection of pathogens like bacteria, viruses, and fungi. The demand for these diagnostics is anticipated to increase, creating a sizable market opportunity, given the continuing threat of emerging infectious diseases like the COVID-19 pandemic. Cancer screening and diagnosis both greatly benefit from DNA probe-based diagnostics. These tests can pinpoint particular genetic alterations or mutations linked to different types of cancer, facilitating early detection and individualized treatment plans. The demand for accurate and dependable DNA probe-based diagnostics in oncology is anticipated to increase as the incidence of cancer continues to rise globally.

Growing Number Of Age-Related Illnesses And Conditions

A growing number of age-related illnesses and conditions are becoming more common as the world’s population ages. Age-related genetic disorders like Alzheimer’s and Parkinson’s disease can be detected early with the help of DNA probe-based diagnostics, enabling prompt treatment and better patient outcomes. In the upcoming years, the market for these diagnostics will be driven by the growing elderly population. DNA probe-based diagnostics are also becoming more popular because they are suitable for point-of-care testing (POCT). POCT enables healthcare providers to conduct quick tests at the patient’s bedside or in distant locations, speeding up turnaround and enabling quicker decision-making. Due to the need for prompt and precise diagnosis, particularly in environments with limited resources, the market for DNA probe-based POCT is anticipated to expand. The sensitivity, specificity, and throughput of DNA probe-based diagnostic techniques have increased thanks to developments in PCR, nucleic acid microarrays, and next-generation sequencing. These technological advancements expand the potential market for DNA probe-based diagnostics by making them more available and affordable.

Competitive Landscape

Key Players

The global DNA probe-based diagnostics market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

Abbott Molecular
Beckman Coulter Inc.
Becton, Dickinson and Company
bioMerieux
F. Hoffmann-La Roche Ltd.
GE Healthcare Life Sciences
Luminex Corporation
QIAGEN N.V.
Siemens Healthineers
Thermo Fischer Scientific Inc.

The major players in the global DNA probe-based diagnostics market constantly strive to stay ahead by introducing new products and innovations.

The market for DNA probe-based diagnostics has probably experienced ongoing technological advancements, including better DNA probe design, improved detection techniques, and more automated and user-friendly diagnostic platforms. The sensitivity, specificity, and effectiveness of DNA probe-based tests are improving.

The market for DNA probe-based diagnostics has likely been impacted by the trend toward point-of-care testing and decentralized healthcare. There may have been initiatives to create quick and portable DNA probe-based testing equipment for hospitals, clinics, and homes.

Beyond infectious diseases and genetic testing, DNA probe-based diagnostics are increasingly used in other fields. The technology has the potential to be used in many different areas, including the detection of drug-resistant pathogens and the monitoring of treatment outcomes.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Summary of Key Findings

The usability and accessibility of DNA probe-based diagnostic platforms have been enhanced by ongoing technological and automated advancements driving market growth
Market segmented by application and region.
Infectious diseases are the most popular, with cancer and genetic predisposition as primary user segments.
DNA probe-based diagnostics offer high specificity and sensitivity for detecting and identifying particular genetic sequences.
Asia Pacific is leading market growth; the market is highly competitive with key players, including Abbott Molecular, Beckman Coulter Inc., Becton, Dickinson and Company, bioMerieux, F. Hoffmann-La Roche Ltd., GE Healthcare Life Sciences, Luminex Corporation

Future Outlook

Positive outlook for the global DNA probe-based diagnostics market with significant growth potential in the Asia Pacific region
The efficiency and cost-effectiveness of DNA probe-based diagnostics to drive growth
Challenges from the complex and constantly changing nature of molecular diagnostics
Key players to focus on product innovation, expanding market reach and maintaining competitive pricing to stay ahead.

Segmentation

By Applications
- Infectious Diseases
- Cancer
- Genetic Predisposition
- Identity/forensics
- Others
By Region

North America
- The US.
- Canada
- Mexico
Europe
- Germany
- France
- The U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: DNA Probe-Based Diagnostics Market
2.2. DNA Probe-Based Diagnostics Market, By Application
2.3. DNA Probe-Based Diagnostics Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. DNA Probe-Based Diagnostics Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Application
3.5.2. Application
3.5.3. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Applications
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Application Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Contracts Marketing
4.7.2. Indirect Contracts Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Application Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. DNA Probe-Based Diagnostics Market, By Application
7.1. DNA Probe-Based Diagnostics Market Overview, by Application
7.1.1. DNA Probe-Based Diagnostics Market Revenue Share, By Application, 2022 Vs 2030 (in %)
7.2. Infectious Diseases
7.2.1. DNA Probe-Based Diagnostics Market, By Region, 2017-2030 (US$ Bn)
7.3. Cancer
7.3.1. DNA Probe-Based Diagnostics Market, By Region, 2017-2030 (US$ Bn)
7.4. Genetic Predisposition
7.4.1. DNA Probe-Based Diagnostics Market, By Region, 2017-2030 (US$ Bn)
7.5. Identity/forensics
7.5.1. DNA Probe-Based Diagnostics Market, By Region, 2017-2030 (US$ Bn)
7.6. Others
7.6.1. DNA Probe-Based Diagnostics Market, By Region, 2017-2030 (US$ Bn)

8. DNA Probe-Based Diagnostics Market, By Region
8.1. DNA Probe-Based Diagnostics Market Overview, by Region
8.1.1. DNA Probe-Based Diagnostics Market, By Region, 2022 vs 2030 (in%)
8.2. Application
8.2.1. DNA Probe-Based Diagnostics Market, By Application, 2017-2030 (US$ Bn)

9. North America DNA Probe-Based Diagnostics Market Analysis
9.1. North America DNA Probe-Based Diagnostics Market, by Application, 2017-2030(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. North America DNA Probe-Based Diagnostics Market, by Country, 2017-2030 (US$ Bn)
9.2.1. North America DNA Probe-Based Diagnostics Market, by Country, 2022 Vs 2030 (in%)
9.2.2. U.S.
9.2.2.1. U.S. DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.2.2.2. U.S. DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
9.2.3. Canada
9.2.3.1. Canada DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.2.3.2. Canada DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
9.2.4. Mexico
9.2.4.1. Mexico DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.2.4.2. Mexico DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)

10. Europe DNA Probe-Based Diagnostics Market Analysis
10.1. Europe DNA Probe-Based Diagnostics Market, by Application, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Europe DNA Probe-Based Diagnostics Market, by Country, 2017-2030 (US$ Bn)
10.2.1. Europe DNA Probe-Based Diagnostics Market, by Country, 2022 Vs 2030 (in%)
10.2.2. Germany
10.2.2.1. Germany DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.2.2. Germany DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
10.2.3. France
10.2.3.1. France DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.3.2. France DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
10.2.4. UK
10.2.4.1. UK DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.4.2. UK DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
10.2.5. Italy
10.2.5.1. Italy DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.5.2. Italy DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
10.2.6. Spain
10.2.6.1. Spain DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.6.2. Spain DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
10.2.7. Rest of Europe
10.2.7.1. Rest of Europe DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.2.7.2. Rest of Europe DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)

11. Asia Pacific DNA Probe-Based Diagnostics Market Analysis
11.1. Asia Pacific DNA Probe-Based Diagnostics Market, by Application, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Asia Pacific DNA Probe-Based Diagnostics Market, by Country, 2017-2030 (US$ Bn)
11.2.1. Asia Pacific DNA Probe-Based Diagnostics Market, by Country, 2022 Vs 2030 (in%)
11.2.2. China
11.2.2.1. China DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.2.2. China DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
11.2.3. Japan
11.2.3.1. Japan DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.3.2. Japan DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
11.2.4. India
11.2.4.1. India DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.4.2. India DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
11.2.5. South Korea
11.2.5.1. South Korea DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.5.2. South Korea DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
11.2.6. South-East Asia
11.2.6.1. South-East Asia DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.6.2. South-East Asia DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
11.2.7. Rest of Asia Pacific
11.2.7.1. Rest of Asia Pacific DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.2.7.2. Rest of Asia Pacific DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)

12. Latin America DNA Probe-Based Diagnostics Market Analysis
12.1. Latin America DNA Probe-Based Diagnostics Market, by Application, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Latin America DNA Probe-Based Diagnostics Market, by Country, 2017-2030 (US$ Bn)
12.2.1. Latin America DNA Probe-Based Diagnostics Market, by Country, 2022 Vs 2030 (in%)
12.2.2. Brazil
12.2.2.1. Brazil DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.2.2.2. Brazil DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
12.2.3. Argentina
12.2.3.1. Argentina DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.2.3.2. Argentina DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
12.2.4. Rest of Latin America
12.2.4.1. Rest of Latin America DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.2.4.2. Rest of Latin America DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)

13. Middle East and Africa DNA Probe-Based Diagnostics Market Analysis
13.1. Middle East and Africa DNA Probe-Based Diagnostics Market, by Application, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Middle East and Africa DNA Probe-Based Diagnostics Market, by Country, 2017-2030 (US$ Bn)
13.2.1. Middle East and Africa DNA Probe-Based Diagnostics Market, by Country, 2022 Vs 2030 (in%)
13.2.2. GCC Countries
13.2.2.1. GCC Countries DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.2.2.2. GCC Countries DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
13.2.3. South Africa
13.2.3.1. South Africa DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.2.3.2. South Africa DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)
13.2.4. Rest of Middle East and Africa
13.2.4.1. Rest of Middle East and Africa DNA Probe-Based Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.2.4.2. Rest of Middle East and Africa DNA probe based-diagnostics, By Application, 2017-2030 (US$ Bn)

14. Company Profiles
14.1. MA Lighting
14.1.1. Company Overview
14.1.2. Applications/Services Portfolio
14.1.3. Geographical Presence
14.1.4. Financial Summary
14.1.4.1. Market Revenue and Net Profit (2019-2022)
14.1.4.2. Business Segment Revenue Analysis
14.1.4.3. Geographical Revenue Analysis
14.2. Abbott Molecular
14.3. Beckman Coulter Inc.
14.4. Becton, Dickinson and Company
14.5. bioMerieux
14.6. F. Hoffmann-La Roche Ltd.
14.7. GE Healthcare Life Sciences
14.8. Luminex Corporation
14.9. QIAGEN N.V.
14.10. Siemens Healthineers
14.11. Thermo Fischer Scientific Inc.

List of Figures
FIG. 1 DNA Probe-Based Diagnostics Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 DNA Probe-Based Diagnostics Market Segmentation
FIG. 4 DNA Probe-Based Diagnostics Market, by Application, 2022 (US$ Bn)
FIG. 5 DNA Probe-Based Diagnostics Market, by Geography, 2022 (US$ Bn)
FIG. 6 Attractive Investment Proposition, by Application, 2022
FIG. 7 Attractive Investment Proposition, by Geography, 2022
FIG. 8 Global Market Share Analysis of Key DNA Probe-Based Diagnostics Market Manufacturers, 2022
FIG. 9 Global Market Positioning of Key DNA Probe-Based Diagnostics Market Manufacturers, 2022
FIG. 10 DNA Probe-Based Diagnostics Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 11 DNA Probe-Based Diagnostics Market, by Infectious Diseases, Value, 2017-2030 (US$ Bn)
FIG. 12 DNA Probe-Based Diagnostics Market, by Cancer, Value, 2017-2030 (US$ Bn)
FIG. 13 DNA Probe-Based Diagnostics Market, by Genetic Predisposition, Value, 2017-2030 (US$ Bn)
FIG. 14 DNA Probe-Based Diagnostics Market, by Identity/forensics, Value, 2017-2030 (US$ Bn)
FIG. 15 DNA Probe-Based Diagnostics Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 16 DNA Probe-Based Diagnostics Market, by GRC Management, 2017-2030 (US$ Bn)
FIG. 17 DNA Probe-Based Diagnostics Market, by Identity Management and Fraud Detectiona, 2017-2030 (US$ Bn)
FIG. 18 North America DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 19 U.S. DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 20 Canada DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 21 Europe DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 22 Germany DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 23 France DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 24 U.K. DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 25 Italy DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 26 Spain DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 27 Rest of Europe DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 28 Asia Pacific DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 29 China DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 30 Japan DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 31 India DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 32 South Korea DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 33 South-East Asia DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 34 Rest of Asia Pacific DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 35 Latin America DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 36 Brazil DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 37 Mexico DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 38 Rest of Latin America DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 39 Middle East & Africa DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 40 GCC Countries DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 41 South Africa DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 42 Rest of Middle East and Africa DNA Probe-Based Diagnostics Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: DNA Probe-Based Diagnostics Market
TABLE 2 DNA Probe-Based Diagnostics Market: Market Drivers Impact Analysis
TABLE 3 DNA Probe-Based Diagnostics Market: Market Restraints Impact Analysis
TABLE 4 DNA Probe-Based Diagnostics Market, by Competitive Benchmarking, 2022
TABLE 5 DNA Probe-Based Diagnostics Market, by Geographical Presence Analysis, 2022
TABLE 6 DNA Probe-Based Diagnostics Market, by Key Strategies Analysis, 2022
TABLE 7 DNA Probe-Based Diagnostics Market, by Infectious Diseases, By Region, 2017-2022 (US$ Bn)
TABLE 8 DNA Probe-Based Diagnostics Market, by Infectious Diseases, By Region, 2023-2030 (US$ Bn)
TABLE 9 DNA Probe-Based Diagnostics Market, by Cancer, By Region, 2017-2022 (US$ Bn)
TABLE 10 DNA Probe-Based Diagnostics Market, by Cancer, By Region, 2023-2030 (US$ Bn)
TABLE 11 DNA Probe-Based Diagnostics Market, by Genetic Predisposition, By Region, 2017-2022 (US$ Bn)
TABLE 12 DNA Probe-Based Diagnostics Market, by Genetic Predisposition , By Region, 2023-2030 (US$ Bn)
TABLE 13 DNA Probe-Based Diagnostics Market, by Identity/forensics, By Region, 2017-2022 (US$ Bn)
TABLE 14 DNA Probe-Based Diagnostics Market, by Identity/forensics, By Region, 2023-2030 (US$ Bn)
TABLE 15 DNA Probe-Based Diagnostics Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 16 DNA Probe-Based Diagnostics Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 17 DNA Probe-Based Diagnostics Market, by GRC Management, By Region, 2017-2022 (US$ Bn)
TABLE 18 DNA Probe-Based Diagnostics Market, by GRC Management, By Region, 2023-2030 (US$ Bn)
TABLE 19 DNA Probe-Based Diagnostics Market, by Identity Management and Fraud Detectiona, By Region, 2017-2022 (US$ Bn)
TABLE 20 DNA Probe-Based Diagnostics Market, by Identity Management and Fraud Detectiona, By Region, 2023-2030 (US$ Bn)
TABLE 21
TABLE 22 DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 23 DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 24 DNA Probe-Based Diagnostics Market, by Region, 2017-2022 (US$ Bn)
TABLE 25 DNA Probe-Based Diagnostics Market, by Region, 2023-2030 (US$ Bn)
TABLE 26 North America DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 27 North America DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 28 North America DNA Probe-Based Diagnostics Market, by Country, 2017-2022 (US$ Bn)
TABLE 29 North America DNA Probe-Based Diagnostics Market, by Country, 2023-2030 (US$ Bn)
TABLE 30 United States DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 31 United States DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 32 Canada DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 33 Canada DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 34 Mexico DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 35 Mexico DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 36 Europe DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 37 Europe DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 38 Europe DNA Probe-Based Diagnostics Market, by Country, 2017-2022 (US$ Bn)
TABLE 39 Europe DNA Probe-Based Diagnostics Market, by Country, 2023-2030 (US$ Bn)
TABLE 40 Germany DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 41 Germany DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 42 France DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 43 France DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 44 United Kingdom DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 45 United Kingdom DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 46 Italy DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 47 Italy DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 48 Spain DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 49 Spain DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 50 Rest of Europe DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 51 Rest of Europe DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 52 Asia Pacific DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 53 Asia Pacific DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 54 China DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 55 China DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 56 Japan DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 57 Japan DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 58 India DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 59 India DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 60 South Korea DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 61 South Korea DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 62 South-East Asia DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 63 South-East Asia DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 64 Rest of Asia Pacific DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 65 Rest of Asia Pacific DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 66 Latin America DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 67 Latin America DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 68 Brazil DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 69 Brazil DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 70 Argentina DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 71 Argentina DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 72 Argentina DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 73 Argentina DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 74 Rest of Latin America DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 75 Rest of Latin America DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 76 Middle East and Africa DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 77 Middle East and Africa DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 78 GCC Countries DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 79 GCC Countries DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 80 South Africa DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 81 South Africa DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)
TABLE 82 Rest of Middle East and Africa DNA Probe-Based Diagnostics Market, by Application, 2017-2022 (US$ Bn)
TABLE 83 Rest of Middle East and Africa DNA Probe-Based Diagnostics Market, by Application, 2023-2030 (US$ Bn)

Frequently Asked Questions

What is the current size of the global DNA probe-based diagnostics market?

The global DNA probe-based diagnostics market was valued at USD 14.2 Billion in 2022.

What is the expected growth rate of the DNA probe-based diagnostics market between 2023 and 2030?

The DNA probe-based diagnostics market is expected to grow at a CAGR of 5.10% between 2023 and 2030, reaching USD 20.11 Billion in 2030.

Which segment is leading the market share in terms of applications?

Infectious diseases is the leading segment by applications, holding over 43% share in value in 2022.

Which application segment governs the demand for DNA probe-based diagnostics worldwide?

The cancer segment governs the demand for DNA probe-based diagnostics worldwide, holding a massive share of over 80% in 2022.

Which segment is expected to post the highest CAGR during the forecast period?

The genetic predisposition segment will post the highest CAGR during the forecast period.

Which region is fueling the growth of the DNA probe-based diagnostics industry?

Asia Pacific is fueling the growth of the DNA probe-based diagnostics industry, with an over one-third share in 2022.

Who are the major players in the global DNA probe-based diagnostics market?

The top players include Abbott Molecular, Beckman Coulter Inc. Becton, Dickinson and Company, bioMerieux, F. Hoffmann-La Roche Ltd., GE Healthcare Life Sciences, Luminex Corporation, QIAGEN N.V., Siemens Healthineers, and Thermo Fischer Scientific Inc.

What are the major market drivers of the DNA probe-based diagnostics industry?

DNA probe-based diagnostic innovation is still driven by ongoing research and development in genomics and molecular diagnostics.

What are the major market restraints of the DNA probe-based diagnostics industry?

Some healthcare providers need help implementing DNA probe-based diagnostics on a broad scale due to the high cost of the tests and the requirement for skilled personnel to perform and interpret them, major market restraints.

What are the major market opportunities of the DNA probe-based diagnostics industry?

With the huge growth potential in the Asia Pacific, Infectious disease prevalence continues to be a significant healthcare concern are the major opportunities in the DNA probe-based diagnostics industry.

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$7699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –